Podcast urges practices to treat valuations as a diagnostic tool: full analysis

A new Uncharted Veterinary Podcast episode is making the case that practice valuation should be treated more like a biopsy than a sale brochure. In episode 396, Dr. Andy Roark interviews David McCormick of Simmons Veterinary Practice Sales and Appraisals about how a valuation can reveal hidden business problems, including poor financial visibility and inefficiencies that may be masked by rising revenue. The central shift is conceptual: valuation is being presented as a strategic diagnostic tool for practice leaders, not just a number to pull when it’s time to exit. (music.amazon.fr)

That framing builds on a longer-running idea in veterinary practice management. A 2012 Today’s Veterinary Practice article by McCormick and Dick Goebel argued that appraisals for management and planning can be a “powerful diagnostic tool” and recommended valuations every three to five years to assess profitability, cash flow, and operational health. In other words, the podcast isn’t introducing a new financial metric so much as reviving an old discipline for a market that has become more complex and more consequential. (todaysveterinarypractice.com)

The timing matters. Multiple 2025 market updates suggest veterinary M&A is still active, but no longer simple. Monarch Practice Transitions reported that valuation multiples in the first half of 2025 generally stabilized around 9x to 12x EBITDA, with top-performing hospitals in attractive markets reaching as high as 15x. The firm also said buyers are paying closer attention to profitability, staffing stability, recruiting conditions, and opportunities for margin improvement, while relying more on seller notes, equity, and earnouts than straightforward cash deals. (monarchpracticetransitions.com)

Ackerman Group’s second-quarter 2025 market update painted a similar, and in some ways sharper, picture. The firm said practice valuations improved through the first half of 2025 after bottoming in the second half of 2023, and that weighted average general practice multiples in its deal data exceeded 12x. But it also described a bifurcated market: larger, high-quality hospitals were drawing the strongest offers, while some smaller practices, older sellers, and less advantaged geographies faced more resistance. Ackerman also reported that the share of deals with at least 70% cash upfront fell from 81% in 2024 to 50% in the first half of 2025, with buyers increasingly using notes and earnouts to protect against downside risk. (ackerman-group.com)

That backdrop helps explain why McCormick’s message may resonate beyond would-be sellers. If a valuation process surfaces weak margins, inconsistent doctor productivity, underperforming service lines, excess inventory, or poor financial reporting, those issues now matter not only for long-term profitability, but also for recruiting, financing, partnership discussions, and eventual transaction terms. In a market where buyers are rewarding scale and predictability, a practice that looks healthy from the outside can still be discounted if its operations don’t hold up under diligence. That is an inference based on the transaction trends described by market advisers, but it aligns closely with the concerns raised in the podcast episode. (music.amazon.fr)

There doesn’t appear to be broad third-party reaction specifically to this episode yet, but the industry commentary around valuations is consistent. Advisers across the sector are emphasizing preparedness, financial clarity, and early appraisal work rather than waiting until a sale process begins. Even seller-focused firms now describe valuation as the first step in “unlocking value,” not merely measuring it. (monarchpracticetransitions.com)

Why it matters: For veterinary professionals, especially practice leaders, the takeaway is practical. A current valuation can help translate business performance into something actionable: where the hospital is creating value, where it is leaking value, and how exposed it may be to staffing, margin, or growth risks. That’s useful whether the goal is independence, partnership, debt financing, succession planning, or a future sale. In today’s market, the same operational fixes that support better patient access and team stability may also strengthen a hospital’s negotiating position. (todaysveterinarypractice.com)

What to watch: Watch for whether 2026 brings continued strength in individual hospital valuations, or whether softer revenue growth and a choppy recapitalization market start to pressure multiples and deal terms, especially for smaller or harder-to-recruit practices. (ackerman-group.com)